NAJClass II
Agents, Embolic, For Treatment Of Uterine Fibroids
21 CFR 870.3300 / Cardiovascular
NAJ is the FDA product code for Agents, Embolic, For Treatment Of Uterine Fibroids, a class II device type, regulated under 21 CFR 870.3300. As of , FDA records hold 8 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- NAJ
- Device name
- Agents, Embolic, For Treatment Of Uterine Fibroids
- Regulation
- 21 CFR 870.3300
- Device class
- Class II
- Review panel
- Cardiovascular
- Submission type
- 510(k)
- Implant
- Yes
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 8
- Ingested recalls
- 1
Clearances, product code NAJ
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2023 | 1 |
Applicants with the most clearances
Product code NAJ| Applicant | Clearances |
|---|---|
| Boston Scientific Corporation | 2 |
| Merit Medical Systems, Inc. | 2 |
| Biosphere Medical, S.A. | 1 |
| Celonova Biosciences, Inc. | 1 |
| Cook Incorporated | 1 |
| Suzhou Hengrui Callisyn Biomedical Co., Ltd. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this code- Biosphere Medical, S.A.
- Boston Scientific Corporation
- Boston Scientific International BV, European Dist. Ctr.
- Cook Incorporated
- Ionisos
- Merit Medical Nederland BV
- Merit Medical Systems, Inc.
- Suzhou Hengrui Hongyuan Medical Co., Ltd.
- Synergy Health Ede BV
- Synergy Health Ireland Ltd
- Synergy Health Westport Ltd
- Terumo Cardiovascular Systems Corporation
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
